10x Genomics, Inc.·4

May 25, 5:48 PM ET

McAnear Justin J. 4

4 · 10x Genomics, Inc. · Filed May 25, 2023

Insider Transaction Report

Form 4
Period: 2023-05-23
McAnear Justin J.
Chief Financial Officer
Transactions
  • Sale

    Class A Common Stock

    2023-05-23$55.06/sh565$31,111100,462 total
  • Sale

    Class A Common Stock

    2023-05-23$55.07/sh194$10,683101,933 total
  • Sale

    Class A Common Stock

    2023-05-23$55.06/sh465$25,604101,468 total
  • Sale

    Class A Common Stock

    2023-05-23$55.06/sh441$24,283101,027 total
Footnotes (2)
  • [F1]The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]Includes 617 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 12, 2023.

Documents

1 file
  • 4
    form4.xmlPrimary